SOL price rallied to $140, but weak derivatives market metrics and stagnate network fees show limited investor confidence. Is a retest of the $160 possible? Key pointsSolana’s activity growth has not offset falling leverage demand and weak network fees, keeping SOL short-term bullish prospects limited.A short squeeze to $160 needs firmer derivatives support and stronger investor conviction amid persistent macroeconomic uncertainty.Read more SOL price rallied to $140, but weak derivatives market metrics and stagnate network fees show limited investor confidence. Is a retest of the $160 possible? Key pointsSolana’s activity growth has not offset falling leverage demand and weak network fees, keeping SOL short-term bullish prospects limited.A short squeeze to $160 needs firmer derivatives support and stronger investor conviction amid persistent macroeconomic uncertainty.Read more

SOL rebounds alongside wider crypto market bounce: Is $160 possible?

2025/11/25 08:30
1 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

SOL price rallied to $140, but weak derivatives market metrics and stagnate network fees show limited investor confidence. Is a retest of the $160 possible?

Key points

Solana’s activity growth has not offset falling leverage demand and weak network fees, keeping SOL short-term bullish prospects limited.

A short squeeze to $160 needs firmer derivatives support and stronger investor conviction amid persistent macroeconomic uncertainty.

Read more

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.